)
)
Humacyte Investor Relations Material
Latest events
Q3 2024
Humacyte
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Humacyte Inc
Access all reports
Humacyte, Inc. engages in developing, manufacturing and commercializing products for off-the-shelf therapy. The company focuses on solid tumors, benign bone growths, and vascular disease. It also manufactures human tissue for other therapies. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
HUMA
Country
🇺🇸 United States